Jump to content

PubMed RSS Feed - - Face-to-face with anti-inflammatory therapy for rosacea.


Recommended Posts

Face-to-face with anti-inflammatory therapy for rosacea.

Exp Dermatol. 2014 Mar 29;

Authors: Salzer S, Ruzicka T, Schauber J

In the past, our understanding of rosacea has been inadequate and limited to descriptions of factors that exacerbate and improve the disease. While the pathophysiology of rosacea is complex and multifactorial, cathelicidin peptides have emerged as key players in the pathogenesis of this common dermatological disorder. This article correlates recent findings in abnormal cathelicidin production and proteolytic processing in rosacea with therapeutic actions of current treatment options and, in this way, highlights potential points of intervention for the development of efficient therapeutic alternatives. This article is protected by copyright. All rights reserved.

PMID: 24684602 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24684602?dopt=Abstract = URL to article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

Terms & Rules